No consideration was payable for the grant of the award. Subject to the terms of the award it will normally vest three years from the date of grant, subject to achievement of the following ...

HELLERUP, Denmark, April 11, 2025 /PRNewswire/ -- Following exercise of 365,096 original RSUs granted in the 2022 Long Term Incentive Program and the 2023 Retention Program, the Board of Directors ...

Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2025 Copenhagen, Denmark, April 19, 2025 – Zealand Pharma A ...

Zealand Pharma (ZLDPF) announces the implementation of long-term incentive programs for 2025 for Zealand Pharma’s Board of Directors, Corporate Management and employees in accordance with ...

For the financial year 2025, the total aggregated value of grants under the Long-term incentive programs, including RSUs and PSUs, cannot exceed 400% of the fixed annual salary for the CEO and 250 ...

Company announcement - No. 9 / 2025 Zealand Pharma launches long-term incentive programs for Zealand Pharma's Board of Directors, Corporate Management and employees for 2025 Copenhagen, Denmark, April ...

For the financial year 2025, the total aggregated value of grants under the Long-term incentive programs, including RSUs and PSUs, cannot exceed 400% of the fixed annual salary for the CEO and 250% ...